Arbutus Biopharma Corp (ABUS)
3.46
+0.02
(+0.58%)
USD |
NASDAQ |
Nov 21, 16:00
3.46
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Market Cap: 655.64M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 651.85M |
| November 19, 2024 | 661.33M |
| November 18, 2024 | 667.01M |
| November 15, 2024 | 689.75M |
| November 14, 2024 | 687.85M |
| November 13, 2024 | 691.64M |
| November 12, 2024 | 689.75M |
| November 11, 2024 | 706.80M |
| November 08, 2024 | 710.59M |
| November 07, 2024 | 706.80M |
| November 06, 2024 | 742.81M |
| November 05, 2024 | 750.39M |
| November 04, 2024 | 733.33M |
| November 01, 2024 | 750.17M |
| October 31, 2024 | 728.39M |
| October 30, 2024 | 746.39M |
| October 29, 2024 | 765.33M |
| October 28, 2024 | 767.22M |
| October 25, 2024 | 752.07M |
| October 24, 2024 | 767.22M |
| October 23, 2024 | 769.12M |
| October 22, 2024 | 763.44M |
| October 21, 2024 | 771.01M |
| October 18, 2024 | 786.17M |
| October 17, 2024 | 780.48M |
| Date | Value |
|---|---|
| October 16, 2024 | 795.64M |
| October 15, 2024 | 778.59M |
| October 14, 2024 | 731.23M |
| October 11, 2024 | 735.02M |
| October 10, 2024 | 717.97M |
| October 09, 2024 | 712.29M |
| October 08, 2024 | 714.18M |
| October 07, 2024 | 706.60M |
| October 04, 2024 | 727.44M |
| October 03, 2024 | 729.34M |
| October 02, 2024 | 738.81M |
| October 01, 2024 | 725.55M |
| September 30, 2024 | 729.34M |
| September 27, 2024 | 723.04M |
| September 26, 2024 | 747.58M |
| September 25, 2024 | 738.14M |
| September 24, 2024 | 758.90M |
| September 23, 2024 | 762.68M |
| September 20, 2024 | 758.90M |
| September 19, 2024 | 781.56M |
| September 18, 2024 | 779.67M |
| September 17, 2024 | 770.23M |
| September 16, 2024 | 804.21M |
| September 13, 2024 | 843.86M |
| September 12, 2024 | 813.65M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
63.82M
Minimum
Apr 03 2020
860.85M
Maximum
Sep 10 2024
384.13M
Average
368.89M
Median
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.09B |
| Amicus Therapeutics Inc | 2.834B |
| Ionis Pharmaceuticals Inc | 5.360B |
| GlycoMimetics Inc | 20.71M |
| FibroGen Inc | 38.92M |
Market Cap Related Metrics
| PS Ratio | 92.54 |
| Price to Book Value | 6.134 |
| Price | 3.46 |
| Earnings Yield | -12.43% |